This well-managed bank has survived the sector's adversity to emerge stronger than ever. Read More

Catastrophe and upheaval around the globe are boosting demand for this undervalued crisis management company. Read More

This American success story has boxed in the competition while richly rewarding shareholders. Read More

Jim critiques James Montier's list of investment principles. For the most part, they're right on the money. Read More

The studio behind Twilight and The Hunger Games is profiting off teen angst like never before. Read More

The beleaguered solar industry could soon find its day in the sun again. Read More

Finding winning stocks that beat the market isn't easy, but academic research points to some stock characteristics that put investment outperformance firmly within your grasp. Read More

The quarterly 13F filing season lets us peek into the minds of top investors. Health care stocks were in during the quarter, while techs were out. Read More

This blue chip pharmaceutical firm has taken it on the chin lately, but several new drugs in the pipeline should hold it in good stead. Read More

Hedge fund manager Dan Loeb’s billion-dollar new stake could pay off big even if the company spurns him. Read More